比较两种左甲状腺素剂量调整算法用于妊娠期原发性甲状腺功能减退女性的随机试验
该随机试验在38次妊娠中比较两种左甲状腺素剂量调整算法:G1采用经验性每周加两片后每周调整片数,G2根据当前TSH和剂量按微克/天持续调整。G1有75%的TSH值在孕期目标范围内,G2为81%(P=0.09),两组剂量调整次数相似,G1在孕早期TSH<0.1 mIU/L的比例更高(P=0.01)。结论认为持续调整法与经验性加量法同样有效。
要点
- G1的TSH达标比例为75%,G2为81%(P=0.09),两组无显著差异。
- G1在孕早期出现TSH<0.1 mIU/L的比例高于G2(P=0.01)。
- 两组每次妊娠所需左甲状腺素剂量调整次数相似(G1 3.1±2.0 vs G2 4.1±3.2,P=0.27)。
核心结论
- 持续调整法与经验性加量法在维持妊娠期甲状腺功能减退女性TSH达标方面同样有效。
研究设计与样本
- 随机试验在华盛顿特区学术内分泌诊所招募33名左甲状腺素剂量稳定的女性,共38次妊娠,妊娠<10周入组,随机分入G1或G2。
- G1采用经验性每周加两片后每周调整片数;G2根据当前TSH水平和左甲状腺素剂量按微克/天持续调整。
- 孕早期和孕中期每2周监测TSH,孕晚期每4周监测一次。
主要发现
- 入组时平均孕龄为6.4±2.1周。
- G1有75%的TSH值在孕期目标范围内,G2为81%(P=0.09)。
- 两组每次妊娠所需左甲状腺素剂量调整次数相似(G1 3.1±2.0 vs G2 4.1±3.2,P=0.27)。
- G1在孕早期出现TSH<0.1 mIU/L的比例高于G2(P=0.01)。
- 甲状腺功能减退病因与TSH达标比例相关,而甲状腺抗体状态与TSH达标比例无关。
临床怎么用
- 作者认为,持续调整法可作为经验性加量法之外用于妊娠期甲状腺功能减退女性左甲状腺素剂量调整的选择。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Regulation of maternal thyroid hormones during pregnancy is crucial for optimal maternal and fetal outcomes. There are no specific guidelines addressing maternal levothyroxine (LT4) dose adjustments throughout pregnancy. OBJECTIVE: To compare two LT4 dose-adjustment algorithms in hypothyroid pregnant women. DESIGN: Thirty-three women on stable LT4 doses were recruited at <10 weeks gestation during 38 pregnancies and randomized to one of two dose-adjustment groups. Group 1 (G1) used an empiric two-pill/week dose increase followed by subsequent pill-per-week dose adjustments. In group 2 (G2), LT4 dose was adjusted in an ongoing approach in micrograms per day based on current thyroid stimulating hormone (TSH) level and LT4 dose. TSH was monitored every 2 weeks in trimesters 1 and 2 and every 4 weeks in trimester 3. SETTING: Academic endocrinology clinics in Washington, DC. MAIN OUTCOME MEASURE: Proportion of TSH values within trimester-specific goal ranges. RESULTS: Mean gestational age at study entry was 6.4 ± 2.1 weeks. Seventy-five percent of TSH values were within trimester-specific goal ranges in G1 compared with 81% in G2 (P = 0.09). Similar numbers of LT4 dose adjustments per pregnancy were required in both groups (G1, 3.1 ± 2.0 vs G2, 4.1 ± 3.2; P = 0.27). Women in G1 were more likely to have suppressed TSH <0.1 mIU/L in trimester 1 (P = 0.01). Etiology of hypothyroidism, but not thyroid antibody status, was associated with proportion of goal TSH values. CONCLUSIONS: We compared two options for LT4 dose adjustment and showed that an ongoing adjustment approach is as effective as empiric dose increase for maintaining goal TSH in hypothyroid women during pregnancy.
引用
- Sullivan SD, Downs E, Popoveniuc G, et al. Randomized Trial Comparing Two Algorithms for Levothyroxine Dose Adjustment in Pregnant Women With Primary Hypothyroidism. J Clin Endocrinol Metab. 2017. PMID: 28911144. doi:10.1210/jc.2017-01086
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。